Resources for healthcare professionals and practices Skip to content

Resources for healthcare professionals and practices

RELiZORB patient enrollment—outpatient and hospital discharge

For a patient to be eligible to receive RELiZORB, the Patient Enrollment Form and the Patient Authorization Form are needed. You and your patient (or their representative) can work together to complete the required forms; just follow these 3 easy steps:

  1. Ask your patient (or their representative) to complete the Patient Authorization Form and sections 1 and 2 of the Patient Enrollment Form
  2. You complete sections 3 through 6 of the Patient Enrollment Form
  3. Submit both completed forms and supporting clinical documentation to RELiZORB Support Services by either emailing them to [email protected] or by faxing them to 1-844-233-3146

Helpful resources

The following resources are for use by healthcare professionals only. Depending on the individual patient you are treating, to help avoid delays in RELiZORB cartridge approval or to assist with managing a denial, the following materials may be helpful.

RELiZORB ordering information for hospitals

RELiZORB is supplied in boxes of 30 cartridges: 1 box = 30 cartridges. The RELiZORB NDC* is 62205000020, and the UDI is 00862205000243.

*Third-party-derived code based on UDI.

Distributor/GPO Product/Contract Number
AmerisourceBergen 10177832
Cardinal (Drug side) 5206982
Cardinal (Medical/Surgical side) 100295
McKesson (Drug side) 3507662
McKesson (Medical/Surgical side) 23564601
Medline Industries LCR2205000020
Morris & Dickson 245555
Intalere/GPO VH11821
Premier/GPO PPPH21ALR01

To order RELiZORB directly from Alcresta Therapeutics

Please send your PO to the following email: [email protected]. GPOs we currently contract with include Intalere and Premier. For pricing information outside those GPOs, or other hospital ordering related questions, please contact Hospital Order Support at [email protected].

HCPCS billing code

Effective January 1, 2019, RELiZORB has a permanent, separately billable Medicare billing code (B4105). In addition, RELiZORB was assigned the PE04 (Enteral Equipment and/or Supplies) Product and Service Code, which may be relevant for certain patients under the July 11, 1984, Medicare National Coverage Determination for Enteral and Parenteral Nutritional Therapy (180.2).

RELiZORB expert case study videos

In these videos, a team of clinical experts explore issues associated with fat malabsorption and how RELiZORB may help address these challenges in patients who require enteral feeding.

Cystic Fibrosis

13-year-old female with Pancreatic Insufficiency

Kay Vavrina, BS, MPA, RD, LD, CNSC

Critical Care

6-year-old G-J tube dependent male admitted to the Pediatric ICU

Melissa Wallinga, MS, RD, CSPCC, LD

Oncology

70-year-old male with Pancreatic Cancer and Pancreaticoduodenectomy

Whitney Christie, MS, RD, CSO, CNSC

Oncology

73-year-old male with Pancreatic Cancer and Pancreatectomy

Whitney Christie, MS, RD, CSO, CNSC

Oncology + Pancreatitis

73-year-old male with Nasopharyngeal Squamous Cell Carcinoma and Pancreatitis

Jaclyn Moore, MS, RD, CSO

Oncology

84-year-old male diagnosed with Pancreatic Adenocarcinoma

Jaclyn Moore, MS, RD, CSO

Trenton’s Story

See how RELiZORB is helping a 17-year old student living with cystic fibrosis

See how RELiZORB is helping a 17-year old student living with cystic fibrosis